Login
Join
FOLLOW:
Subscribe Free
Magazine
eNewsletter
Checkout
Menu
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 25
Directory
Microsites
Events
More
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 25
Directory
Microsites
Events
Current / Back Issue
Features
Editorial
Columns
Digital Edition
eNewsletter Archive
Our Team
Editorial Guidelines
Subscribe Now
Advertise Now
Top Features
Small Innovators & Niche CROs
Focus on Science
Rapid and Data Rich Chromatographic Method Development
Preparing Your Post Pandemic Talent Strategy
How Modern Near-Infrared Came to Be
Breaking News
Online Exclusives
Industry News
Collaborations & Alliances
Promotions & Moves
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
CRO News
Live From Shows
Top News
Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
Ascendia Pharmaceuticals Poised for Expansion
Bora Pharmaceuticals Adds Roller Compaction Capabilities
Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
AGC Biologics Appoints Jun Takami GM of Chiba Site
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
Ascendia Pharmaceuticals Poised for Expansion
Bora Pharmaceuticals Adds Roller Compaction Capabilities
Alkermes, Merck Enter Clinical Trial and Supply Agreement
Sterling Pharma Solutions Acquires ADC Biotechnology
Moderna, Catalent Enter Long-Term Strategic Vax Pact
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Cryoport Acquires Critical Transport Solutions Australia
PharmParts – This Makes Sense!
Securing Your API Supply Chain: Three Keys to Success
Enteris BioPharma: Custom Solutions – From Bench to Market
The Benefits of Outsourcing Cold Storage
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
Ascendia Pharmaceuticals Poised for Expansion
Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
Agilex Biolabs Acquires TetraQ for APAC Expansion Plans
Alkermes, Merck Enter Clinical Trial and Supply Agreement
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
What Will Change at FDA for 2021?
RBQM Comes of Age: COVID as a Catalyst for Change
Post-Pandemic Regulations
Enteris BioPharma: Custom Solutions – From Bench to Market
Metrics Contract Services Completes Russian Regulatory Inspection
Companies
Categories
Corporate Capabilities
Add New Company
Contract Service Directory Companies
Almac Group
Alcami
PCI Pharma Services
Adare Pharma Solutions
Baxter BioPharma Solutions
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Jobs
Contract Service Directory Companies
PCI Pharma Services
Quotient Sciences
Emergent BioSolutions
Almac Group
Reed-Lane
Webinars
Live From Shows
Magazine
Current / Back Issue
Features
Editorial
Columns
Editorial Guidelines
Subscribe Now
Advertise Now
Enewsletter Archive
Digital Edition
Directory
Companies
Categories
Corporate Capabilities
Add Your Company
Manufacturing
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
cGMP Manufacture
Packaging
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Development
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Compliance
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Top 25 Pharma & BioPharma
Contract Pharma Direct
Breaking News
Online Exclusives
Slideshows
Experts Opinions
Surveys
Outsourcing Survey
Salary Survey
Glossary
Videos
Podcasts
White Papers
Infographics
Contract Pharma Conference
Contract Pharma Conference
Speakers
Exhibitors
Conference Sessions
Supplier Microsite
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
eBook
Webinars
Events
Industry Events
Live from Show Events
Webinars
Classifieds / Job Bank
Classifieds
Job Bank
About Us
About Us
Contact Us
Advertise With Us
Privacy Policy
Terms of Use
Search Results for '
astellas
'
Search For:
Refine by Dates:
From:
To:
Past 7 Days
|
Past 30 Days
Refine By Content:
All
Advanced Degrees
Ask The Board
Ask The Experts
Back Page
Bio News & Views
Blog
Breaking News
Business Corner
Buyers Guide Companies
Case Studies
Classifieds
Columns
Company Blog
Conference Sessions
Content Microsite
Ebook
Editorial
Executive Perspective
Expert's Opinion
FDA Watch
Features
Financial Analysis
Getting Results
Glossary
I Mak
India Report
Industry Events
Infographics
Jobs
Literature / Brochures
Live From Shows
Lowe Down
Managing Your Career
News Releases
Online Exclusives
Outsourcing Survey
Pharma Beat
Podcasts
Posters
Preclinical Outsourcing
Product Releases
Salary Survey
Services
Slideshows
Sponsored Content
Top 25 Pharma & BioPharma
Top Companies Report
Trials & Filings
Videos
Webinars
White Papers / Tech Papers
Bio News
|
Breaking News
|
Collaborations & Alliances
|
Industry News
Astellas Partners with LabCentral for ‘Golden Ticket Competition’
Provides access to life-science incubator and in-house Astellas expertise.
Contract Pharma Staff
07.23.20
22 Astellas
...
Kristin Brooks, Managing Editor, Contract Pharma
07.20.20
Breaking News
|
Drug Development
|
Industry News
Astellas, Seattle Genetics PADCEV Gains Breakthrough Designation
In combination with Merck's anti-PD-1 therapy KEYTRUDA for the treatment of advanced or metastatic urothelial cancer
02.19.20
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
Astellas, Adaptimmune Enter CAR-T Alliance
Aims to develop new stem-cell derived allogeneic T-cell therapies to treat cancer
01.14.20
Drug Development
|
Industry News
Astellas Acquires Xyphos Biosciences
Gains novel and proprietary ACCEL (Advanced Cellular Control through Engineered Ligands) technology platform
01.02.20
Trials & Filings
XTANDI Approved for mCSPC
The first oral treatment in three distinct types of advanced prostate cancer –non-metastatic and metastatic castration-resistant prostate cancer (CRPC).
Astellas
12.17.19
Biologics, Proteins, Vaccines
|
Breaking News
|
Drug Development
|
Drug Discovery
|
Industry News
Astellas to Fund Boston-Area Cell and Gene Therapy Start-Up
Invests $12.5 million to support LabCentral Incubators in Boston's Life Science Community
10.01.19
Promotions & Moves
Astellas Appoints SVP and Head Clinical and Research QA
Fryrear, brings more than 30 years of pharmaceutical industry experience, holding senior leadership roles at AbbVie and Eli Lilly
08.06.19
Top 25 Pharma and Biopharma Companies
(Based on 2018 Pharma/Biopharma Sales, in $U.S. Millions)
Tim Wright & Kristin Brooks
07.18.19
Astellas, Frequency Therapeutics Enter Alliance for Hearing Loss Treatment
Aims to develop and commercialize Frequency’s candidate, FX-322, for the treatment of sensorineural hearing loss
07.17.19
Top 25 Pharma and Biopharma Companies
...
07.15.19
22 ASTELLAS
...
07.15.19
10 Amgen
...
07.15.19
The Top Companies Report
Combined sales for 2018 topped the $600 billion mark
Tim Wright, Editor
07.15.19
Astellas Appoints National Oncology Sales VP
Chelsea Glinski is recognized by the Healthcare Businesswomen's Association (HBA) as a 2019 Luminary
07.10.19
APIs
|
Breaking News
|
Industry News
Otsuka Chemical Enters API Business
Acquires cefixime business from Astellas
06.18.19
Promotions & Moves
Astellas Makes Senior-level Appointments
Benner named president and head of development, Guan named senior vice president and head of Medical Affairs
04.04.19
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
|
Industry News
ReForm Biologics, Astellas Form Collaboration
Will use ReForm’s technology to help progress Astellas’ biologics pipeline
03.06.19
Biologics, Proteins, Vaccines
|
Breaking News
|
Drug Development
|
Industry News
CytomX Acquires Agensys’ CD3-based Bispecific Technologies
Transaction provides novel payloads and CD3 binding moieties for next wave of potent anti-cancer agents
01.07.19
Breaking News
|
Drug Development
|
Industry News
Astellas Pharma Acquires Potenza Therapeutics
Successful collaboration results in three INDs with the potential to treat various cancers
12.17.18
Industry News
|
Promotions & Moves
Astellas Announces Key Promotion
Geoff Towle has been promoted to vice president, Oncology Marketing, Astellas US
09.19.18
Promotions & Moves
Astellas Appoints Latin America VP
Fernandez responsible for leading operations and growth across Latin America
08.24.18
Drug Development
|
Industry News
Astellas Pharma Acquires Quethera
Gains ophthalmic gene therapy program
08.10.18
Bio News
|
Industry News
|
Promotions & Moves
Astellas Announces Management Changes
The changes include the positions of VP, Oncology, Medical Affairs, and VP, & executive director, Corporate Communications
07.24.18
Top 25 Pharma and Biopharma Companies
Combined sales for 2017 reached $599 billion. (Based on 2017 Pharma/Biopharma Sales, in $U.S. Millions)
07.23.18
23 ASTELLAS
...
07.20.18
Top 25 Pharma and Biopharma Companies
...
07.20.18
cGMP Manufacture
|
Collaborations & Alliances
|
Drug Development
|
Facilities
|
Industry News
Eurofins, Astellas Sign Outsourcing Agreement
Astellas has committed to provide ASL work covering its current capacity for an agreed period of time
05.29.18
Biologics, Proteins, Vaccines
|
Drug Development
|
Industry News
Kite Pharma Continues Expansion Efforts
New facilities will support cell therapy R&D and manufacture
05.15.18
Breaking News
|
Collaborations & Alliances
|
Drug Discovery
|
Industry News
|
R&D
Actinium, Astellas Form Research Partnership
Will utilize Actinium's AWE Technology Platform to generate Actinium Radio-Conjugates on selected Astellas targeting agents
03.29.18
Promotions & Moves
Astellas Appoints Ethics & Compliance Head
Dragovic to oversee Ethics & Compliance efforts globally
03.28.18
Drug Development
|
Trials & Filings
Astellas Achieves Breakthrough Designation for Urothelial Cancer ADC
Enfortumab vedotin is being evaluated in metastatic urothelial cancer in patients previously treated with CPIs
03.26.18
Promotions & Moves
Astellas Pharma Names Americas Ops President
Barretto-Ko to lead the company's North and South America operations
03.15.18
Bio News
|
Drug Development
|
Promotions & Moves
Alkermes Appoints New COO
Jim Robinson brings over 25 years of experience to the company
03.01.18
Collaborations & Alliances
|
Drug Development
|
Drug Discovery
|
Industry News
Astellas Acquires Universal Cells
For a payment of up to $102.5 million of upfront and milestones
02.14.18
Promotions & Moves
Astellas Makes Leadership Changes in Canada and U.S.
Sabus appointed GM of Astellas Pharma Canada; Gerber and O'Keefe promoted to new roles in U.S. sales organization
01.09.18
Promotions & Moves
Astellas Names Americas Finance VP
Fiordaliso to oversee managerial reporting and budgeting, financial planning and analysis, revenue forecasting
12.13.17
Promotions & Moves
Astellas Names GM for Brasil Ops
Britto brings more than 25 years of pharmaceutical industry experience
12.05.17
Breaking News
|
Clinical Trials
|
Drug Development
|
Drug Discovery
|
Industry News
Astellas Buys Mitobridge in $450M Deal
Accelerates the discovery and development of drugs for mitochondrial function
12.04.17
Contract Pharma Direct eNewsletter Archive Old
...
11.09.17
Promotions & Moves
Astellas Appoints RWI VP
Crisel responsible for overseeing Real World Informatics & Analytics
11.02.17
Promotions & Moves
Astellas Appoints Specialty, Medical Affairs VP
Thal will assume overall responsibility for the strategic direction of the Specialty product portfolio
10.31.17
Bio News
|
Breaking News
|
Facilities
|
Industry News
Seattle Genetics Buys Bothell Mfg. Facility from BMS
Facility provides manufacturing capacity and flexibility to support growing pipeline
08.03.17
Clinical Trials
|
Drug Development
|
Promotions & Moves
Astellas Appoints Three Senior Development Heads
Fleishaker, Gronen, and Krivoshik to lead clinical, data, and oncology departments
05.01.17
Breaking News
|
Promotions & Moves
Astellas Names President of Astellas US Technologies
John DeMay will be responsible for collaboration and cooperation across pharmaceutical technology divisions
04.04.17
Drug Development
|
Industry News
Astellas to Acquire Ogeda SA
Expands late-stage assets
04.03.17
Biologics, Proteins, Vaccines
|
Collaborations & Alliances
Astellas, Affinivax in Global MAPS Vax Pact
To develop and commercialize a vaccine targeting pneumococcus
02.28.17
Drug Development
|
Industry News
Astellas Pharma to Acquire Ganymed
Adds several oncology assets in preclinical and clinical development
10.31.16
Promotions & Moves
Astellas Expands Oncology Leadership
Brenner responsible for global leadership for Oncology, Keating responsible for all phases of Clinical programs
10.05.16
Breaking News
|
Facilities
|
Industry News
Avara Acquires Astellas U.S. Manufacturing Facility
Will continue to manufacture certain Astellas pharmaceutical products on a contract basis
08.09.16
Trending
Sterling Pharma Solutions Acquires ADC Biotechnology
Ascendia Pharmaceuticals Poised For Expansion
Sanofi To Build New $700M Flu Vaccine Facility In Canada
Frontage Expands Capabilities At Its Clinical Site In Secaucus, NJ
Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
Breaking News
Bora Pharmaceuticals Adds Roller Compaction Capabilities
Ascendia Pharmaceuticals Poised for Expansion
Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
AGC Biologics Appoints Jun Takami GM of Chiba Site
View Breaking News >
CURRENT ISSUE
April 2021
Small Innovators & Niche CROs
Focus on Science
Rapid and Data Rich Chromatographic Method Development
Preparing Your Post Pandemic Talent Strategy
How Modern Near-Infrared Came to Be
Securing Your API Supply Chain: Three Keys to Success
View More >